JUSTIN COTTRELL: Open Payments
NPI 1316051402 · LOMA LINDA, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,460 in 66 payments from 17 companies in 2025. Trend: 2023 $1,037 · 2024 $2,391 · 2025 $1,460
Food & beverage: $1,460
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 17 | $294 |
| ABBVIE INC. | 11 | $239 |
| REVANCE THERAPEUTICS, INC. | 1 | $115 |
| Novartis Pharmaceuticals Corporation | 4 | $110 |
| Regeneron Healthcare Solutions, Inc. | 4 | $94 |
| Arcutis Biotherapeutics, Inc. | 4 | $93 |
| Galderma Laboratories, L.P. | 4 | $85 |
| Amgen Inc. | 3 | $71 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 3 | $71 |
| Organon LLC | 4 | $58 |
Products named: CIBINQO, SKYRIZI, DAXXIFY, COSENTYX, Zoryve, DUPIXENT, Otezla, NEMLUVIO.
Industry payments across CA — which companies pay providers there.
